PlainRecalls
FDA Drug Low Class III Terminated

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

Reported: March 14, 2018 Initiated: February 28, 2018 #D-0581-2018

Product Description

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

Reason for Recall

Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.

Details

Units Affected
19,664 100-bottles
Distribution
Nationwide in the USA
Location
Marietta, GA

Frequently Asked Questions

What product was recalled?
Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10. Recalled by Osmotica Pharmaceutical Corp. Units affected: 19,664 100-bottles.
Why was this product recalled?
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 14, 2018. Severity: Low. Recall number: D-0581-2018.